Acknowledgement to Reviewers

Intervirology · Published 2025-01-01 · Available online 17 Dec 2024 · Journal article · DOI 10.1159/000541959

Authors being retrieved — see the publisher record. https://doi.org/10.1159/000541959

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year: 2025

Related articles

SARS-COV-2 Triggers the Development of Class I and Class II HLA Antibodies in Recovered Convalescent Plasma Donors · Intervirology · 2022 · Same journal
Global prevalence of pre-existing antibodies against human adenoviruses, surveyed from 1962-2021 · Intervirology · 2024 · Same journal
Hepatitis E Virus Capsid as a Carrier of Exogenous Antigens for the Development of Chimeric Virus-Like Particles · Intervirology · 2021 · Same journal
Comparison of a Multiplex Real-Time PCR Technique with Oxford Nanopore Technologies Next-Generation Sequencing for Identification of SARS-CoV-2 Variants of Concern · Intervirology · 2023 · Same journal
Evaluation of Sandwich Enzyme-Linked Immunosorbent Assay and Reverse Transcription Polymerase Chain Reaction for the Diagnosis of Foot-and-Mouth Disease · Intervirology · 2021 · Same journal
Low-Intensity Ultrasound as a Novel Strategy to Improve the Cytotoxic Effect of Oncolytic Reovirus on Colorectal Cancer Model Cells · Intervirology · 2021 · Same journal
Structures of SARS-CoV-2 RNA-Binding Proteins and Therapeutic Targets · Intervirology · 2021 · Same journal
Identification and Verification of Ubiquitin D as a Gene Associated with Hepatitis C Virus-Induced Hepatocellular Carcinoma · Intervirology · 2022 · Same journal
Incidence of HPVs, EBV, and MMTV-Like Virus in Breast Cancer in Qatar · Intervirology · 2022 · Same journal
Evaluation of IL-1β and IL-6 Expression following EBNA-1 and BRLF-1 Peptide Treatment in Epstein-Barr Virus-Positive Multiple Sclerosis Patients · Intervirology · 2022 · Same journal